Abstract
BackgroundPancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancers, highly resistant to standard chemotherapy and immunotherapy. Regulatory T cells (Tregs) expressing tumor necrosis factor α receptor 2 (TNFR2)...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have